Regulatory Exclusivities or Non-patent exclusivities

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Reversing Category Exclusivities in Infant Perceptual Categorization: Simulations and Data

Threeto four-month-old infants presented with a series of cat or dog photographs show an unusual asymmetry in the exclusivity of the perceptual category representations formed. We have previously accounted for this asymmetry in terms of an inclusion asymmetry in the distribution of features present in the cat and dog images used during familiarization (Mareschal, French, & Quinn, 2000). We use ...

متن کامل

Fixed-Dose Combination Drug Approvals, Patents and Market Exclusivities Compared to Single Active Ingredient Pharmaceuticals

INTRODUCTION Fixed-dose combinations (FDC) contain two or more active ingredients. The effective patent and exclusivity life of FDC compared to single active ingredient has not been assessed. OBJECTIVES Trends in FDA approved FDC in the period 1980-2012 and time lag between approval of FDC and single active ingredients in the combination were assessed, and the effective patent and exclusivity...

متن کامل

Patents v. Statutory Exclusivities in Biological Pharmaceuticals - Do We Really Need Both

id=2020112. 175. Compound claims are patent claims drafted specifically to cover a particular chemical or biological compound or a group of particular compounds defined by structure, function, or characteristics (e.g., melting point, X-ray diffraction pattern, solubility, density). 176. See Grabowski et al., supra note 5, at 4 ("Patent protection alone may be insufficient for biologics in the c...

متن کامل

Guardians at the gate: Biosimilar and patent reform legislation could fundamentally change the guards for therapeutic monoclonal antibodies--Part 2.

Patent protection and FDA exclusivities are the two principal forms of protection available to companies that develop therapeutic monoclonal antibodies. Propo-sed changes to both forms of protection are currently being debated in the United States Congress. Specifically, Congress is presently debating both biosimilar and patent reform legislations. Although no bill has yet passed, it is expecte...

متن کامل

A novel independence test for somatic alterations in cancer shows that biology drives mutual exclusivity but chance explains co-occurrence

Just like recurrent somatic alterations characterize cancer genes, mutually exclusive or co-occurring alterations across genes suggest functional interactions. Identifying such patterns in large cancer studies thus helps the discovery of unknown interactions. Many studies use Fisher’s exact test or simple permutation procedures for this purpose. These tests assume identical gene alteration prob...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Civil & Legal Sciences

سال: 2016

ISSN: 2169-0170

DOI: 10.4172/2169-0170.1000205